Just learned about MVX, the Metabolic Vulnerability Index, which is used to estimate ACM within a 1-5 year period. Attia had the inventor of this biomarker on his latest podcast.
AI summary:
How the MVX Metabolic Test Works
The Metabolic Vulnerability Index (MVX) is a nuclear magnetic resonance (NMR) spectroscopy blood test designed to estimate near-term (5-year) all-cause mortality risk and physiological vulnerability.
It calculates a composite score (1–100) by quantifying six circulating plasma biomarkers divided into two sub-indices:
Inflammation Vulnerability Index (IVX): Measures systemic inflammation and vascular risk using glycoprotein acetyls (GlycA) and small high-density lipoprotein particles (sHDL-P) .
Metabolic Malnutrition Index (MMX): Evaluates protein-energy malnutrition and dysmetabolism using citrate and branched-chain amino acids (leucine, isoleucine, and valine) .
By merging inflammatory signals with cellular energy and nutritional status, MVX captures the combined impact of metabolic dysfunction and chronic systemic wasting (“metabolic malnutrition-inflammation syndrome”), providing risk stratification beyond traditional clinical risk factors.
Comparison to Other Inflammation Markers
Marker
Biological Target
Primary Limitation / Difference
Key Advantage of MVX
hs-CRP (High-Sensitivity C-Reactive Protein)
Single acute-phase liver protein
Rapidly spikes from acute infections, injuries, or localized inflammation, causing false-positive noise for chronic systemic risk.
MVX pairs chronic inflammatory signals with metabolic and nutritional reserves, reflecting cumulative physiological frailty rather than transient acute spikes.
GlycA (Glycoprotein Acetyls)
N-glycan side chains on acute-phase proteins
Measures chronic systemic inflammation accurately, but lacks context on cellular energy balance or protein wasting.
GlycA is actually a component of MVX (within the IVX sub-score). MVX enhances GlycA by adding metabolic substrates (citrate, BCAAs) and lipoprotein particle metrics.
IL-6 / TNF alpha Pro-inflammatory cytokines
High diurnal variability and short plasma half-lives make routine standardized testing difficult.
MVX markers are stable in plasma and measured simultaneously in a single, automated NMR run.
Here are some scientific papers published since 2020 that evaluate or utilize the Metabolic Vulnerability Index (MVX) for analysis:
1. Heart Failure Mortality Prediction
2. Cross-Sectional HF Cohort & Clinical Trial Comparison
3. Interplay with Thyroid Function & Mortality
4. Subclinical Thyroid Disorders & Metabolic Vulnerability
5. Ophthalmic Risk Stratification (AMD)
6. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2 Likes
What separates this risk marker from other risk markers? It’s mainly 2 things:
what it measures is not organ-specific, which is why the studies listed above are not limited to a single organ (liver, eyes, thyroid)
it doesn’t depend on age. As a simplified example, it’s able to assign a higher score to someone with a 30-year old patient with untreated FH, vs someone in their 60s with LDL under 55.
It is stable, unlike hsCRP and IL-6 levels, which makes it useful for tracking levels for people with chronic diseases.
Fuller explanation from AI:
Most traditional risk markers are either disease-specific (like troponin for cardiac injury or HbA1c for diabetes) or heavily confounded by age (like frailty scores, where age does most of the heavy lifting statistically).
MVX stands out for two fundamental reasons:
1. It Measures a “Common Final Pathway” (Systemic Wasting & Stress)
Instead of looking for a specific damaged organ, MVX quantifies the crosstalk between two universal drivers of human disease: chronic micro-inflammation and cellular energy depletion .
Whether someone has advanced heart failure, metabolic liver disease (MASLD), severe kidney dysfunction, or late-stage age-related macular degeneration (AMD), the body eventually enters a shared physiological state called Metabolic Malnutrition-Inflammation Syndrome :
The Inflammatory Side (IVX): Chronic vascular and tissue stress (driven by GlycA and sHDL-P depletion).
The Metabolic Wasting Side (MMX): Amino acid catabolism and mitochondrial energy deficits (reflected in Citrate and BCAA drops).
Because almost every major chronic disease ends up draining cellular energy reserves while fanning the flames of low-grade inflammation, MVX acts as a universal “physiologic stress meter.”
2. It Captures Biological Vulnerability Independent of Chronological Age
Age is often a blunt tool in clinical medicine. Two 68-year-olds can look entirely different on a biological level—one might be robust and active, while the other is experiencing subtle, systemic frailty.
MVX is uniquely valuable because it measures biological age and reserve capacity :
It uncouples age from risk: In large epidemiological studies (like the UK Biobank and PREVEND cohorts), when researchers adjust for age, MVX remains an independent predictor of 5- to 15-year mortality.
Younger high-risk detection: A younger patient with early-stage disease might have normal routine lab panels (like normal liver enzymes or normal hs-CRP), but an elevated MVX score reveals that their cells are already under metabolic and inflammatory strain.
1 Like